CPRIT awards newly integrated UT San Antonio to further its mission to combat cancers across South Texas

June 2, 2026

The University of Texas at San Antonio and its academic health center, UT Health San Antonio, recently received over $2.7 million in new academic and prevention awards from the Cancer Prevention and Research Institute of Texas (CPRIT) to further its mission of combating cancers across South Texas. Since 2010, CPRIT has awarded the newly integrated UT San Antonio almost $186 million.





KABB TV (Fox SA): Focus on South Texas

May 24, 2026

Colton Jones, MD, hematology and oncology fellow at UT Health San Antonio, the academic health center of The University of Texas at San Antonio (UT San Antonio), was interviewed for this news segment.   Watch Now


AI-assisted colonoscopy enhances polyp detection

May 20, 2026

UT Health San Antonio is using AI-assisted colonoscopy technology to help physicians detect precancerous polyps in real time, expanding access to advanced colorectal cancer prevention and early detection for South Texans.

A doctor holds a human colon anatomy model, demonstrating the digestive system's structure to diagnose and treat various gastrointestinal diseases and conditions.


UT Health San Antonio researcher awarded $2.1M award to study cellular structures

May 19, 2026

Like a busy restaurant kitchen, our cells depend on well-organized working spaces to assemble the “recipes” that keep the body healthy. UT San Antonio scientist, David Libich, PhD, recently received a five-year, $2.1 million Maximizing Investigators’ Research Award from the National Institute of General Medical Sciences to study how certain proteins form these organizational hubs and what happens when things do not go according to plan.

A digital illustration of stem cells.


Drug shows promise for halting chronic pain before it starts

May 19, 2026

Scientists at The University of Texas at San Antonio (UT San Antonio) are investigating a major immune system pathway that leads to the development of chronic pain and a drug that has the potential to stop the process in its tracks. Their study, published April 22 in Cell Reports, is the first of its kind to show a path toward the prevention of chronic pain.